These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25103319)

  • 1. Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging.
    Schumacher FF; Nunes JP; Maruani A; Chudasama V; Smith ME; Chester KA; Baker JR; Caddick S
    Org Biomol Chem; 2014 Oct; 12(37):7261-9. PubMed ID: 25103319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation.
    Morais M; Forte N; Chudasama V; Baker JR
    Methods Mol Biol; 2019; 2033():15-24. PubMed ID: 31332744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging disulfides for stable and defined antibody drug conjugates.
    Badescu G; Bryant P; Bird M; Henseleit K; Swierkosz J; Parekh V; Tommasi R; Pawlisz E; Jurlewicz K; Farys M; Camper N; Sheng X; Fisher M; Grygorash R; Kyle A; Abhilash A; Frigerio M; Edwards J; Godwin A
    Bioconjug Chem; 2014 Jun; 25(6):1124-36. PubMed ID: 24791606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
    Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
    ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
    Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
    Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous antibody-drug conjugates via site-selective disulfide bridging.
    Forte N; Chudasama V; Baker JR
    Drug Discov Today Technol; 2018 Dec; 30():11-20. PubMed ID: 30553515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'.
    Schumacher FF; Sanchania VA; Tolner B; Wright ZV; Ryan CP; Smith ME; Ward JM; Caddick S; Kay CW; Aeppli G; Chester KA; Baker JR
    Sci Rep; 2013; 3():1525. PubMed ID: 23519366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridged Cysteine Conjugations.
    Bird M; Nunes J; Frigerio M
    Methods Mol Biol; 2020; 2078():113-129. PubMed ID: 31643053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation.
    Castañeda L; Maruani A; Schumacher FF; Miranda E; Chudasama V; Chester KA; Baker JR; Smith ME; Caddick S
    Chem Commun (Camb); 2013 Sep; 49(74):8187-9. PubMed ID: 23929130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers.
    Ohri R; Bhakta S; Fourie-O'Donohue A; Dela Cruz-Chuh J; Tsai SP; Cook R; Wei B; Ng C; Wong AW; Bos AB; Farahi F; Bhakta J; Pillow TH; Raab H; Vandlen R; Polakis P; Liu Y; Erickson H; Junutula JR; Kozak KR
    Bioconjug Chem; 2018 Feb; 29(2):473-485. PubMed ID: 29425028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.
    Liu-Shin LP; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(8):1190-1199. PubMed ID: 30339473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific antibody-drug conjugation through glycoengineering.
    Zhou Q; Stefano JE; Manning C; Kyazike J; Chen B; Gianolio DA; Park A; Busch M; Bird J; Zheng X; Simonds-Mannes H; Kim J; Gregory RC; Miller RJ; Brondyk WH; Dhal PK; Pan CQ
    Bioconjug Chem; 2014 Mar; 25(3):510-20. PubMed ID: 24533768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific and hydrophilic ADCs through disulfide-bridged linker and branched PEG.
    Shao S; Tsai MH; Lu J; Yu T; Jin J; Xiao D; Jiang H; Han M; Wang M; Wang J
    Bioorg Med Chem Lett; 2018 May; 28(8):1363-1370. PubMed ID: 29559276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
    Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
    Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative binding of disulfide-bridged PEG-Fabs.
    Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
    Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody-drug conjugate (ADC).
    Nunes JP; Morais M; Vassileva V; Robinson E; Rajkumar VS; Smith ME; Pedley RB; Caddick S; Baker JR; Chudasama V
    Chem Commun (Camb); 2015 Jul; 51(53):10624-7. PubMed ID: 26051118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemically re-bridging disulfide bonds and the discovery of a thiomaleimide mediated photodecarboxylation of C-terminal cysteines.
    Richards DA; Fletcher SA; Nobles M; Kossen H; Tedaldi L; Chudasama V; Tinker A; Baker JR
    Org Biomol Chem; 2016 Jan; 14(2):455-459. PubMed ID: 26603469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
    Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.